Skip to Main content Skip to Navigation
Journal articles

Induction of Immunogenic Tumor Cell Death by Attenuated Oncolytic Measles Virus

Abstract : Antitumor virotherapy is a developing approach to treat cancer with oncolytic viruses, namely replicative viruses that exclusively or preferentially infect and kill tumor cells. Attenuated strains of Measles Virus (MV) are now being used as oncolytic viruses in clinical trials to treat several types of cancer. The efficacy of oncolytic viruses is mainly due to their capacity to infect and kill tumor cells, but it has also been demonstrated that their capacity to induce immunogenic cell death can activate an antitumor immune response. In this review, we describe the oncolytic capacity of MV and the concept of Immunogenic Cell Death (ICD). We then review how MV induces immunogenic cell death, which can be beneficial for cancer treatment.
Complete list of metadata

Cited literature [101 references]  Display  Hide  Download
Contributor : Nicolas Boisgerault Connect in order to contact the contributor
Submitted on : Wednesday, May 6, 2015 - 10:07:26 AM
Last modification on : Thursday, April 7, 2022 - 10:10:22 AM
Long-term archiving on: : Wednesday, April 19, 2017 - 6:20:56 PM


Publisher files allowed on an open archive




Carole Achard, Nicolas Boisgerault, Tiphaine Delaunay, Frédéric Tangy, Marc Grégoire, et al.. Induction of Immunogenic Tumor Cell Death by Attenuated Oncolytic Measles Virus. Journal of Clinical and Cellular Immunology, OMICS Publishing Group, 2015, 6 (1), ⟨10.4172/2155-9899.1000291⟩. ⟨inserm-01148993⟩



Record views


Files downloads